Cabaser SWISSPHARMA

An Overview of Cabaser, a Potent Dopamine Agonist

Cabaser is a prescription dopamine agonist developed by SwissPharma to manage hyperprolactinemia and assist with Parkinson's symptoms. As an ergot derivative, it selectively stimulates pituitary D2 receptors, suppressing prolactin overproduction and its associated issues like menstrual problems and infertility. For hyperprolactinemia, Cabaser is usually the first treatment attempted due to its potency and tolerability advantage over bromocriptine. It may also reduce Parkinson's disease motor fluctuations as an add-on or sole therapy in mild cases.

Mechanism and Indications

Cabaser binds selectively to D2 receptors, shutting off abnormal prolactin secretion at its source in the pituitary. Approved to treat prolactinomas, galactorrhea and hypogonadism, it brings prolactin levels—and symptoms—back within normal ranges. Parkinson's patients find that Cabaser lessens "off" episodes and improves motor control, especially when started early in the disease process.

Dosing and Administration

Hyperprolactinemia dosing begins at 0.25 mg twice weekly, increasing up to 1 mg with biweekly adjustments as needed. For Parkinson's, individualized daily regimens range from 0.5 to 2 mg total. Take with food and follow-up monitoring is important to examine heart and lung function over the course of treatment.

Safety Information

Contraindications include ergotism history, valvular heart disease and pulmonary fibrosis. Use cautiously in liver or kidney impairment and adjust dose accordingly. Monitor for interactions when combined with CYP inhibitors like erythromycin. Common side effects are nausea, headache and fatigue, but hypotension, pulmonary issues and psychiatric changes require prompt reporting.

Patient Guidance

Cabaser tablets must be stored below 25°C in their original package away from moisture. Regular checkups are necessary to evaluate any new cardiac, pulmonary or neuropsychiatric symptoms. Consult your provider with questions about proper administration, side effects or drug interactions. Discover the precision and effectiveness of SwissPharma's Cabaser for prolactin and Parkinson's disorders.